Clinical Updates

Despite concerns that rotavirus vaccines might raise infants’ risk of blocked bowels, a new study finds that hospitalization rates for… »   

Medtronic Inc on Wednesday said it received regulatory approval for the first remote glucose monitor that will let parents check… »   

For those that live with chronic pain, or are in post-traumatic mode from an injury or surgery, opiate derivatives such… »   

According to government inspectors from the U.S. Department of Health and Human Services (HHS), strong psychiatric medications are often prescribed… »   

The U.S. Food and Drug Administration approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release… »   

ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), and an international specialty pharmaceutical company, announces that the… »   

GlaxoSmithKline Plc executive German Pasteris is in charge of an Alzheimer’s treatment that is years from reaching the market, if… »   

Will a drug used to treat childhood acute lymphoblastic leukemia and other pediatric cancers cause heart problems later in life?

Acetazolamide, a drug commonly used to prevent acute mountain sickness, may reduce symptoms for some people who use it, a… »   

Pfizer and GlaxoSmithKline are increasing sales of cut-price pneumonia vaccine to developing countries by more than 50 percent, marking the… »   

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released… »   

U.S. drug advisers recommended approving an experimental treatment from Alexza Pharmaceuticals for calming down patients with schizophrenia or bipolar disorder,… »   

An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood… »   

U.S. health advisers recommended a revision of labels for the widely used new generation of birth control pills, based on… »   

A new study of leukemia drug Mylotarg, pulled from the U.S. market last year due to safety concerns, found it… »